INTU
42
-10
SWK
64
-4
ITW
49
7
PCG
72
-5
FDX
64
10
AMAT
33
-16
VNO
42
2
FLR
38
2
IBM
50
2
TEL
69
-5
MMM
42
-3
MU
66
-2
USB
62
-3
PH
55
-4
XYL
64
-2
PSA
40
3
STT
50
-6
KR
49
-11
ADI
65
-2
DTE
47
-3
INTU
42
-10
SWK
64
-4
ITW
49
7
PCG
72
-5
FDX
64
10
AMAT
33
-16
VNO
42
2
FLR
38
2
IBM
50
2
TEL
69
-5
MMM
42
-3
MU
66
-2
USB
62
-3
PH
55
-4
XYL
64
-2
PSA
40
3
STT
50
-6
KR
49
-11
ADI
65
-2
DTE
47
-3
Financhill
Back

Dave- Ordinary Shares - Class A Vs. Nektar Therapeutics Industry Stock Comparison

Buy
59

DAVE
Dave- Ordinary Shares - Class A

Last Price:
$202.08
Seasonality Move:
5.25%
Buy
62

NKTR
Nektar Therapeutics

Last Price:
$27.39
Seasonality Move:
6.79%
Buy
59
Dave- Ordinary Shares - Class A (DAVE) is a Buy

Is Dave- Ordinary Shares - Class A a Buy, Sell or Hold?

  • The current Dave- Ordinary Shares - Class A [DAVE] share price is $201.39. The Score for DAVE is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
  • DAVE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
62
Nektar Therapeutics (NKTR) is a Buy

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $27.26. The Score for NKTR is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • NKTR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

DAVE Stock Price Chart

What is Dave- Ordinary Shares - Class A's stock price today?

  • The Dave- Ordinary Shares - Class A share price today is $201.39
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DAVE is experiencing slight buying pressure.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $27.26
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NKTR is experiencing slight selling pressure.

DAVE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 46.67 Buy
Relative Strength Index (14 RSI): 46.24 Sell
Chaikin Money Flow: 112540 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (190.93 - 226.61) Sell
Bollinger Bands (100): (112.62 - 236.74) Buy

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.04 Buy
Relative Strength Index (14 RSI): 66.02 Buy
Chaikin Money Flow: -23288 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (22.49 - 25.51) Buy
Bollinger Bands (100): (8.3 - 22.66) Buy

DAVE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 193.1 Buy
20-day SMA: 209.48 Sell
50-day SMA: 221.47 Sell
200-day SMA: 130.63 Buy
8-day EMA: 194.2 Buy
20-day EMA: 154.83 Buy
50-day EMA: 89.54 Buy
200-day EMA: 27.52 Buy

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 24.13 Buy
20-day SMA: 23.8 Buy
50-day SMA: 20.82 Buy
200-day SMA: 15.1 Buy
8-day EMA: 24.9 Buy
20-day EMA: 23.86 Buy
50-day EMA: 21.15 Buy
200-day EMA: 16.63 Buy

Dave- Ordinary Shares - Class A Earnings Growth & DAVE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.75 per share, an increase next quarter of $0.63 per share, an increase this year of $5.84 per share, and an increase next year of $0.61 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.01 per share, an increase this year of $2.16 per share, and a decrease next year of $1.84 per share.

Dave- Ordinary Shares - Class A Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):